The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nimotuzumab plus chemotherapy in the posterior-line treatment for lung adenocarcinoma with third-generation epidermal growth factor receptor-tyrosine kinase inhibitors resistance.
 
Kaihua Lu
No Relationships to Disclose
 
Meiling Zhang
No Relationships to Disclose
 
Qian Wang
No Relationships to Disclose
 
Ao Sun
No Relationships to Disclose
 
Yan Xiang
No Relationships to Disclose
 
Jingwen Liu
No Relationships to Disclose